Heather Zhang

425 total citations
14 papers, 237 citations indexed

About

Heather Zhang is a scholar working on Infectious Diseases, Molecular Biology and Genetics. According to data from OpenAlex, Heather Zhang has authored 14 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Heather Zhang's work include HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Heather Zhang is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Heather Zhang collaborates with scholars based in United States, Canada and China. Heather Zhang's co-authors include Jeffrey G. Reitz, Erin Quirk, Xuelian Wei, Hal Martin, Kirsten White, Gene W. Voskuhl, Andrew Cheng, Melanie Thompson, Joel E. Gallant and Edwin DeJesus and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Heather Zhang

13 papers receiving 228 citations

Peers

Countries citing papers authored by Heather Zhang

Since Specialization

Citations

This map shows the geographic impact of Heather Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Zhang more than expected).

Fields of papers citing papers by Heather Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Zhang. The network helps show where Heather Zhang may publish in the future.

Co-authorship network of co-authors of Heather Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Zhang. A scholar is included among the top collaborators of Heather Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Zhang. Heather Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	A first-in-human phase 1a dose-escalation study of BGB-15025 (HPK1 inhibitor) as monotherapy and in combination with tislelizumab (TIS; anti-PD-1 antibody) in patients (pts) with advanced solid tumors. 2024 ·Journal of Clinical Oncology ·Sanjeev Deva, Caicun Zhou, (unknown), Peter K. H. Lau, Ben Tran, Yi Ba, Matt D. Galsky, Yongsheng Wang, Yanqiao Zhang, (unknown), Victoria A. Chang, Cunjing Yu, (unknown), Heather Zhang, (unknown), (unknown), Timothy A. Yap	4
2	PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES 2023 ·HemaSphere ·Constantine S. Tam, Mazyar Shadman, Jeff P. Sharman, Gavin Cull, Tycel Phillips, Judith Trotman, Aileen Cohen, (unknown), (unknown), Richard Delarue, Heather Zhang, (unknown), (unknown), Ying Ou, Ian W. Flinn	1
3	Human and nonclinical disposition of [¹⁴C]bictegravir, a potent integrase strand-transfer inhibitor for the treatment of HIV-1 infection 2022 ·Xenobiotica ·Raju Subramanian, John Ling, Jianhong Wang, Kelly Wang, (unknown), Haolun Jin, Yurong Lai, Bernard P. Murray, (unknown), Heather Zhang, Bill J. Smith	4
4	Human pharmacokinetics prediction with an in vitro–in vivo correction factor approach and in vitro drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy^® for the treatment of HIV-1 infection 2022 ·Xenobiotica ·Raju Subramanian, Jianhong Wang, Bernard P. Murray, Joseph M. Custodio, (unknown), Scott E. Lazerwith, (unknown), Judy Mwangi, Hailing Sun, Jennifer Tang, Kelly Wang, Gerry Rhodes, (unknown), Heather Zhang, Bill J. Smith	3
5	In vitro investigations into the roles of CYP450 enzymes and drug transporters in the drug interactions of zanubrutinib, a covalent Bruton's tyrosine kinase inhibitor 2021 ·Pharmacology Research & Perspectives ·Heather Zhang, Ying Ou, Dan Su, Fan Wang, Lai Wang, Srikumar Sahasranaman, Zhiyu Tang	9
6	Human Mass Balance and Metabolite Profiling of [¹⁴C]‐Pamiparib, a Poly (ADP‐Ribose) Polymerase Inhibitor, in Patients With Advanced Cancer 2021 ·Clinical Pharmacology in Drug Development ·Song Mu, D. Palmer, Richard J. Fitzgerald, Claudia Andreu‐Vieyra, Heather Zhang, Zhiyu Tang, Dan Su, Srikumar Sahasranaman	5
7	P176 Clinical pharmacology of the HIV integrase strand transfer inhibitor bictegravir 2017 ·Sexually Transmitted Infections ·Heather Zhang, Joseph M. Custodio, Xuelian Wei, Hui Wang, (unknown), John Ling, Hal Martin, Erin Quirk, (unknown), Brian P. Kearney	10
8	Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial 2017 ·The Lancet Child & Adolescent Health ·(unknown), Aditya H. Gaur, Pope Kosalaraksa, (unknown), Natella Rakhmanina, Danielle Porter, (unknown), Heather Zhang, Cheryl Pikora, Martin S. Rhee	22
9	Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1–Infected Adults 2017 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Joel E. Gallant, Melanie Thompson, Edwin DeJesus, Gene W. Voskuhl, Xuelian Wei, Heather Zhang, Kirsten White, Andrew Cheng, Erin Quirk, Hal Martin	78
10	Pharmacokinetic drug–drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus 2014 ·Clinical Pharmacology in Drug Development ·(unknown), Jolene Kay Berg, (unknown), Nicola Pannacciulli, (unknown), Mildred D. Gottwald, Heather Zhang, (unknown), Ori Ben‐Yehuda, (unknown)	27
11	Globalization and workplace performance in Canada: Cross-sectional and dynamic analyses of productivity and wage outcomes 2012 ·Research in Social Stratification and Mobility ·Heather Zhang, Michael R. Smith	1
12	On the use of indicators of the generosity of unemployment compensation in quantitative cross-national research 2011 ·International Journal of Comparative Sociology ·Michael R. Smith, Heather Zhang	3
13	Comparisons of the success of racial minority immigrant offspring in the United States, Canada and Australia 2011 ·Social Science Research ·Jeffrey G. Reitz, Heather Zhang, (unknown)	40
14	Preparation and Optimization of a Series of 3-Carboxamido-5-phenacylaminopyrazole Bradykinin B1 Receptor Antagonists 2007 ·Journal of Medicinal Chemistry ·(unknown), Albert W. Garofalo, Jon E. Hawkinson, D S Hom, Jacek Jagodziński, (unknown), Martin L. Neitzel, Michael A. Pleiss, Balázs Szőke, Jay S. Tung, (unknown), Jing Wu, Heather Zhang	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact